BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 11963785)

  • 1. [Prognostic factors in head-neck carcinomas].
    Weber A; Tannapfel A
    HNO; 2002 Jan; 50(1):35-42. PubMed ID: 11963785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Improved prognostic assessment of head-neck carcinomas by new genetic markers].
    Bockmühl U; Küchler I; Petersen I
    HNO; 2000 Jun; 48(6):451-6. PubMed ID: 10929226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [p53 mutations/p53 protein overexpression. Differential significance for the progression of head-neck carcinomas].
    Bosch FX; Homann N; Conradt C; Dietz A; Erber R
    HNO; 1999 Sep; 47(9):833-48. PubMed ID: 10525616
    [No Abstract]   [Full Text] [Related]  

  • 4. [Immunohistochemical determination of cell cycle regulatory proteins. No prognostic significance in advanced squamous epithelial carcinomas of the head-neck area].
    Kunz C; Bosch FX; Klein-Kühne W; Nollert J; Rudat V; Conradt C; Dietz A
    HNO; 2003 Oct; 51(10):800-5. PubMed ID: 14523533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prognostic significance of cell-cycle regulatory proteins for outcome after primary radiochemotherapy in patients with advanced head and neck cancer].
    Haas S; Bosch FX; Klein-Kühne W; Nollert J; Rudat V; Conradt C; Dietz A
    HNO; 1999 Sep; 47(9):777-86. PubMed ID: 10525606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prognostic significance of immunohistochemical studies].
    Montenarh M
    HNO; 2003 Oct; 51(10):787-9. PubMed ID: 14523530
    [No Abstract]   [Full Text] [Related]  

  • 7. [Investigations to the influence of tumor supressor gene p16 inactivation on the prognosis of head and neck squamous cell carcinoma].
    Koscielny S; V Eggeling F; Dahse R
    Laryngorhinootologie; 2004 Jun; 83(6):374-80. PubMed ID: 15197677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of CXCL12 and CXCR4 in inoperable head and neck squamous cell carcinoma.
    Rave-Fränk M; Tehrany N; Kitz J; Leu M; Weber HE; Burfeind P; Schliephake H; Canis M; Beissbarth T; Reichardt HM; Wolff HA
    Strahlenther Onkol; 2016 Jan; 192(1):47-54. PubMed ID: 26374452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors in squamous cell carcinoma of the head and neck.
    Wendt TG; Bank P
    Onkologie; 2002 Jun; 25(3):208-12. PubMed ID: 12119454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Basics of tumor development and importance of human papilloma virus (HPV) for head and neck cancer].
    Wittekindt C; Wagner S; Mayer CS; Klußmann JP
    Laryngorhinootologie; 2012 Mar; 91 Suppl 1():S1-26. PubMed ID: 22456913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Influence of glutathione s-transferase and cytochrome p450 polymorphisms on prognosis of head and neck cancer].
    Matthias C; Jahnke V; Fryer AA; Strange RC
    Laryngorhinootologie; 2002 Jun; 81(6):406-12. PubMed ID: 12063626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene therapy for head and neck cancer.
    Gleich LL
    Laryngoscope; 2000 May; 110(5 Pt 1):708-26. PubMed ID: 10807351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Molecular biology and immunohistochemical prognostic markers in head and neck squamous epithelial carcinomas].
    Schmidt M; Hoppe F
    Laryngorhinootologie; 2000 Dec; 79(12):719-29. PubMed ID: 11199454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of numerical aberrations of chromosomes X and 11 and poor prognosis in squamous cell carcinomas of the head and neck.
    Xie X; Clausen OP; Boysen M
    Arch Otolaryngol Head Neck Surg; 2006 May; 132(5):511-5. PubMed ID: 16702567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic relevance of p16 inactivation in head and neck cancer.
    Koscielny S; Dahse R; Ernst G; von Eggeling F
    ORL J Otorhinolaryngol Relat Spec; 2007; 69(1):30-6. PubMed ID: 17085950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Translational research in head and neck cancer. Biological characteristics and general aspects].
    Dietz A; Wichmann G
    HNO; 2011 Sep; 59(9):874-84. PubMed ID: 21861150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current potential and limitations of molecular diagnostic methods in head and neck cancer.
    Mahfouz ME; Rodrigo JP; Takes RP; Elsheikh MN; Rinaldo A; Brakenhoff RH; Ferlito A
    Eur Arch Otorhinolaryngol; 2010 Jun; 267(6):851-60. PubMed ID: 20037788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mechanisms of invasiveness of cancers of the head and neck region].
    Simon C; Simon M; Zenner HP
    HNO; 2001 Nov; 49(11):902-9. PubMed ID: 11759242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential molecular prognostic markers for lymph node metastasis in head and neck squamous cell carcinoma.
    Rodrigo JP; Suárez C; Ferlito A; Devaney KO; Petruzzelli GJ; Rinaldo A
    Acta Otolaryngol; 2003 Jan; 123(1):100-5. PubMed ID: 12625582
    [No Abstract]   [Full Text] [Related]  

  • 20. Which is the single most important factor in deciding the management and determining the prognosis of head and neck cancer?
    Ferlito A; Takes RP; Rinaldo A; Devaney KO
    Eur Arch Otorhinolaryngol; 2010 Mar; 267(3):325-6. PubMed ID: 19823861
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.